BIAL launches a new drug for Parkinson’s Disease.
BIAL, the largest Portuguese pharmaceutical company, saw its second research drug approved by the FDA.
It is a drug for Parkinson’s Disease that will start being marketed in the USA by the end of this year.
Portugal is a country open to business, which has not stopped producing and innovating in face of the COVID-19 crisis.
START NEW BUSINESS WITH PORTUGUESE COMPANIES.
If you are interested in this company and its products or services and want to know more, please fill out the below form. We will get back to you shortly.